Market Tracker

06/30 5:16pm ET

Novo Nordisk A/S (NYSE:NVO)

53.78
Delayed Data
As of Jun 30
 +0.77 / +1.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-7.40%
Year-to-Date

Today’s Trading

Previous close53.01
Today’s open53.51
Day’s range52.96 - 54.02
Volume2,279,487
Average volume (3 months)1,397,982
Market cap$103.9B
Dividend yield1.78%
Data as of 4:03pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.93%
Revenue growth (last year)+1.43%
P/E ratio4.0
Price/Sales9.38
Price/Book19.75

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.88+2.07%
SNYSanofi+0.59+1.43%
ABBVAbbVie+0.10+0.16%
AGNAllergan+0.54+0.23%
Data as of 4:04pm ET, 06/30/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts